Work

Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents

Year: 2024

Type: article

Abstract: This study investigated the real-world incidence rate of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents. A retrospective cohort of 479 adult patients was assessed between January 2015 and July 2023. Overall, a rare rate of 0.4% (2/479) of possible serotonin syndrome with tedizolid was identified. Given that concomitant serotonergic agents were commonly used, further study is warranted to determine causality.

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.00870-24

Authors: Yingsi Fang, Lloyd G. Clarke, Brandon J. Smith, Sunish Shah

Institutions: University of Pittsburgh Medical Center, University of Pittsburgh

Language: English

Topic: Electroconvulsive Therapy Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4402272595